Sort
48,018 grants matching “immunotherapy”
Melanoma-associated retinopathy: detection and mechanisms
$385,000Catherine W Morgans · Oregon Health & Science University · R01 · FY2020 · EY
Clinical Scholars Biomedical Research Training Program
$384,985Ping Chi · Sloan-Kettering Inst Can Research · T32 · FY2020 · CA
Understanding the Mechanism of Mucosal Immunotherapy
$384,948Arvil Wesley Burks · Univ Of North Carolina Chapel Hill · R01 · FY2012 · AI
Core B: Animal Model and Immunotyping Core
$384,934Thomas Alan Hamilton · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA
Mycophenylate mofetil for treatment of chronic GVHD
$384,925Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Mycophenylate mofetil for treatment of chronic GVHD
$384,925Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Mechanisms of Resistance to Gemtuzumab Ozogamicin
$384,925Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
$384,921Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
$384,912Rachael Ann Clark · Brigham And Women'S Hospital · U01 · FY2024 · CA
Strategies to Enhance Adoptive Transfer T Cell Clones
$384,876Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironment
$384,870Ling Gao · Southern California Inst For Res/Educ · R01 · FY2025 · CA
Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironment
$384,870Ling Gao · Southern California Inst For Res/Educ · R01 · FY2022 · CA
Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis
$384,868Benjamin Izar · Columbia University Health Sciences · U54 · FY2023 · CA
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$384,867Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2019 · CA
B cell-dependent anti-tumor immunity in ovarian cancer
$384,851Jose R Conejo-Garcia · Duke University · U01 · FY2022 · CA
SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses
$384,819Kirill A Afonin · University Of North Carolina Charlotte · R35 · FY2023 · GM
Laboratory and Clinical studies on T-cells recognizing NSCLC
$384,815James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$384,750Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$384,750Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Synergy of Radiation and Immunotherapy: New Approaches
$384,750Yang-Xin Fu · Ut Southwestern Medical Center · R01 · FY2017 · CA
Synergy of Radiation and Immunotherapy: New Approaches
$384,750Yang-Xin Fu · Ut Southwestern Medical Center · R01 · FY2018 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$384,750Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Engineering Protein Modulators of Notch Activation for T-cell immunotherapy
$384,750Joseph M. Muretta · University Of Minnesota · R33 · FY2025 · CA
Engineering Protein Modulators of Notch Activation for T-cell immunotherapy
$384,750Joseph M. Muretta · University Of Minnesota · R33 · FY2023 · CA
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
$384,690Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2011 · AI